Skip to main content
. 2020 Aug 12;10:13609. doi: 10.1038/s41598-020-70603-z

Table 3.

Laboratory test and treatment in preterm infants with PV–IVH who deteriorated or not.

Variables Deterioration of PV–IVH
n = 42
No deterioration of PV–IVH
n = 472
X2 P
WBC > 25 × 109/La (n, %) 15 (35.7) 95 (20.1) 5.571 0.02
CRP > 8 mg/L (n, %) 14 (33.3) 86 (18.2) 5.622 0.02
Progressive decrease in platelets (n, %) 4 (9.5) 27 (5.7) N 0.31
Abnormal coagulation (n, %) 7 (16.7) 142 (30.1) 3.373 0.07
Blood glucose < 2.2 mmol/L (n, %) 1 (2.4) 48 (10.2) 2.713 0.10
Albumin < 30 g/L (n, %) 15 (35.7) 209 (44.3) 1.151 0.28
Invasive respiratory support (n, %) 26 (61.9) 149 (31.6) 15.807 0.00
Non-invasive respiratory support (n, %) 2 (4.8) 22 (4.7) N 1.00
Pulmonary surfactant (n, %) 29 (69.0) 240 (50.8) 5.121 0.02
Dopamine (n, %) 22 (52.4) 108 (22.9) 17.763 0.00
Antibiotics (n, %) 11 (26.2) 264 (55.9) 13.714 0.00
Plasma transfusion (n, %) 2 (4.8) 14 (3.0) N 0.38
Intravenous immunoglobulin (n, %) 2 (4.8) 52 (11.0) 1.605 0.21

PV–IVH periventricular–intraventricular hemorrhage, WBC white blood cell, CRP C-reactive protein.

aBaseline values were tested before or within PV–IVH diagnosis.